rs11858480

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003978.5(PSTPIP1):​c.915C>T​(p.Cys305Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.023 in 1,602,812 control chromosomes in the GnomAD database, including 817 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.041 ( 221 hom., cov: 33)
Exomes 𝑓: 0.021 ( 596 hom. )

Consequence

PSTPIP1
NM_003978.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.94

Publications

9 publications found
Variant links:
Genes affected
PSTPIP1 (HGNC:9580): (proline-serine-threonine phosphatase interacting protein 1) This gene encodes a cytoskeletal protein that is highly expressed in hemopoietic tissues. This protein functions via its interaction with several different proteins involved in cytoskeletal organization and inflammatory processes. It binds to the cytoplasmic tail of CD2, an effector of T cell activation and adhesion, downregulating CD2-triggered adhesion. It binds PEST-type protein tyrosine phosphatases (PTP) and directs them to c-Abl kinase to mediate c-Abl dephosphorylation, thereby, regulating c-Abl activity. It also interacts with pyrin, which is found in association with the cytoskeleton in myeloid/monocytic cells and modulates immunoregulatory functions. Mutations in this gene are associated with PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) syndrome. It is hypothesized that the disease-causing mutations compromise physiologic signaling necessary for the maintenance of a proper inflammatory response. [provided by RefSeq, Mar 2016]
PSTPIP1 Gene-Disease associations (from GenCC):
  • pyogenic arthritis-pyoderma gangrenosum-acne syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • autoinflammatory syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • recurrent infections-inflammatory syndrome due to zinc metabolism disorder syndrome
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 15-77032938-C-T is Benign according to our data. Variant chr15-77032938-C-T is described in ClinVar as [Benign]. Clinvar id is 259212.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.94 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.093 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSTPIP1NM_003978.5 linkc.915C>T p.Cys305Cys synonymous_variant Exon 12 of 15 ENST00000558012.6 NP_003969.2 O43586-1A0A0S2Z5P3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSTPIP1ENST00000558012.6 linkc.915C>T p.Cys305Cys synonymous_variant Exon 12 of 15 1 NM_003978.5 ENSP00000452746.1 O43586-1

Frequencies

GnomAD3 genomes
AF:
0.0407
AC:
6199
AN:
152134
Hom.:
221
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0954
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.0158
Gnomad ASJ
AF:
0.0207
Gnomad EAS
AF:
0.0633
Gnomad SAS
AF:
0.0371
Gnomad FIN
AF:
0.0288
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0150
Gnomad OTH
AF:
0.0378
GnomAD2 exomes
AF:
0.0280
AC:
6408
AN:
228940
AF XY:
0.0272
show subpopulations
Gnomad AFR exome
AF:
0.102
Gnomad AMR exome
AF:
0.0127
Gnomad ASJ exome
AF:
0.0160
Gnomad EAS exome
AF:
0.0632
Gnomad FIN exome
AF:
0.0301
Gnomad NFE exome
AF:
0.0154
Gnomad OTH exome
AF:
0.0245
GnomAD4 exome
AF:
0.0211
AC:
30630
AN:
1450560
Hom.:
596
Cov.:
31
AF XY:
0.0213
AC XY:
15380
AN XY:
720466
show subpopulations
African (AFR)
AF:
0.0929
AC:
3093
AN:
33298
American (AMR)
AF:
0.0133
AC:
580
AN:
43592
Ashkenazi Jewish (ASJ)
AF:
0.0169
AC:
436
AN:
25782
East Asian (EAS)
AF:
0.0701
AC:
2761
AN:
39380
South Asian (SAS)
AF:
0.0380
AC:
3207
AN:
84402
European-Finnish (FIN)
AF:
0.0309
AC:
1584
AN:
51316
Middle Eastern (MID)
AF:
0.0188
AC:
108
AN:
5752
European-Non Finnish (NFE)
AF:
0.0156
AC:
17222
AN:
1107118
Other (OTH)
AF:
0.0274
AC:
1639
AN:
59920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
1482
2964
4445
5927
7409
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
768
1536
2304
3072
3840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0408
AC:
6211
AN:
152252
Hom.:
221
Cov.:
33
AF XY:
0.0408
AC XY:
3038
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0955
AC:
3968
AN:
41540
American (AMR)
AF:
0.0158
AC:
241
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0207
AC:
72
AN:
3470
East Asian (EAS)
AF:
0.0634
AC:
328
AN:
5170
South Asian (SAS)
AF:
0.0369
AC:
178
AN:
4828
European-Finnish (FIN)
AF:
0.0288
AC:
306
AN:
10620
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0149
AC:
1015
AN:
68004
Other (OTH)
AF:
0.0369
AC:
78
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
314
628
942
1256
1570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
243
Bravo
AF:
0.0421
Asia WGS
AF:
0.0640
AC:
223
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pyogenic arthritis-pyoderma gangrenosum-acne syndrome Benign:3
Oct 25, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
2.5
DANN
Benign
0.55
PhyloP100
-2.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11858480; hg19: chr15-77325279; API